期刊文献+

两种剂型硝呋太尔制霉素治疗阴道炎的费用-效果分析

Two Formulations Tanner's Treatment with the Ordinances is the Cost of the Effect Analysising
下载PDF
导出
摘要 目的比较硝呋太尔制霉素阴道软胶囊与硝呋太尔制霉菌素阴道栓治疗阴道炎的费用-效果。方法筛选中山市人民医院门诊2009年10月至2011年10月间234例确诊为阴道炎的患者。将之随机分成A、B两组,A组给予硝呋太尔制霉菌素阴道栓.B组给予硝呋太尔制霉素阴道软胶囊,观察疗效并对有效率、痊愈率、平均费用及总有效平均费用进行统计,分析二种剂型的费用-效果差异。结果A、B组的总有效率分别为9636%和98.32%,无显著差异;但B组的痊愈率高于A组(74.30%vs50.91%,P〈0.05),并且,B组总显效费用-效果比及痊愈的费用-效果比均低于A组。结论两种剂型硝呋太尔制霉素对阴道炎治疗总有效率无显著差异,但硝呋太尔制霉素阴道软胶囊的痊愈率明显高于阴道栓.并且费用也相对较低。因此,硝呋太尔制霉素阴道软胶囊从费用一效果上优于阴道栓剂,在临床运用上值得推广。 Object To explore the economic effect of using Nifuratel and Nysfungin Vaginal Soft Capsules and Nifuratel+Nifurateland NystatinVaginal Suppositories to treat vaginitis.Methods 234 patients diagnosed as vaginitis from October,2009 to October,2011 from outpatient of People's Hospital of Zhougshan City was selected for research.They were randomly divided into two groups which were given different medicines respectively:group A: Nifuratel+Nifurateland NystatinVaginal Suppositories and other medicines while group B: Nifuratel and Nysfungin Vaginal Soft Capsules and other medicines.And the analysis of costs and effects was performed by SPAA Software package.Results the total efficiency rates of group A and group B are 96.36% ,98.32 % respectively;cure rates 50.91% ,74.30% respectively;average costs RMB134.0538,RMB 105.2773 respectively;total effective average costs RMB 125.5656,RMB111.3422.Conclusion though total efficiency rates of two medicines for vaginitis are of no evident disparity,their cure rates differ greatly from each other. Economically group B has price advantage and satisfied clinical effect and is the ideal medicine for vaginitis which well worth s clinical application.
出处 《医学信息》 2012年第6期342-343,共2页 Journal of Medical Information
关键词 阴道炎 硝呋太尔制霉菌素阴道栓 硝呋太尔制霉素阴道软胶囊 费用与效果 vaginitis Nifuratel+Nifurateland NystatinVaginal Suppositories Nifuratel and Nysfungin Vaginal Soft Capsules cost and effect economic analysis
  • 相关文献

参考文献10

二级参考文献27

  • 1沈汝棡,聂妍,何芳,刘凯波,李禾,丁辉.北京市围产期妇女生殖道感染监测与分析[J].中华围产医学杂志,2004,7(5):259-261. 被引量:12
  • 2丁玉玲,杨红云.伊曲康唑(美扶)治疗念珠菌性阴道炎疗效观察[J].中国麻风皮肤病杂志,2006,22(1):61-61. 被引量:4
  • 3[1]Pal Z,Dosa E,Pal A.Bacterial vaginosis and other vaginal infections.Int J Gynaecol Obstet,2005,89:278-279.
  • 4[2]Ries AJ.Treatment of vaginal infections:candidiasis,bacterial vaginosis,and trichomoniasis.J Am Pharma Assoc,1997,NS37:563-569.
  • 5[3]Polatti F,Nappi RE,Brundu B,et al.Clinical study on the dose-effect relationship of a Nifuratel-Nystatin combination in the treatment of vulvovaginal infections.Arzneim Forsch Drug Res,2003,53:730-737.
  • 6[5]De-Seta F,Sartore A,Piccoli M.Bacterial vaginosis and preterm delivery:an open question.J Reprod Med,2005,50:313-318.
  • 7[6]El-Din SS,Reynolds MT,Ashbee HR.Investigation into the pathogenesis of vulvo-vaginal candidosis.Sex Transm Infect,2001,77:179-183.
  • 8[7]Parazzini F,Cintio E,Chianten V,et al.Determinants of different candida species infections of the genital tract in women,Sporachrom Study Group.Eur J Obstet Gynecol Reprod Biol,2002,93:141-145.
  • 9[8]Mendling W,Poli A,Magnani P.Clinical effects of nifuratel in vulvovaginal infections.A meta-analysis of metronidazole -controlled trials.Arzneim Forsch Drug Res,2002,52:725-730.
  • 10Toomey KE, Moran JS, Rafferty MP, et al. Epidemiological consideration of sexually transmitted diseases in underserved population. Infect Dis Clin North Am, 1993,7:739-752.

共引文献270

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部